Explore All Access
Check if your research matches the topics covered in Therapeutic Advances in Hematology?
- Degree of match
- Common matching concepts
- Additional journal recommendations
Therapeutic Advances in Hematology : Impact Factor & More
eISSN: 2040-6215pISSN: 2040-6207
Open AccessShare this on:
Check your submission readiness
Find out how your manuscript stacks up against 24 technical compliance and 6 language quality checks.
Therapeutic Advances in Hematology Key Metrics
CiteScore 
0.7
H-Index
32
Impact Factor
< 5
SJR
Q2Hematology
SNIP
0.36
Time to Publish
View Chart Mo
Time to Publish
Sign up now and unlock a detailed chart of Time to publish for this journal
% of papers by time taken from submission to publication
0 to 3 months2%
4 to 6 months28%
7 to 9 months40%
Above 9 months30%
Did you find this useful?
Topics Covered on Therapeutic Advances in Hematology
Hemoglobin
Immune thrombocytopenia
Bortezomib
Conventional chemotherapy
Hematopoietic stem cell transplantation
Blinatumomab
Copanlisib
Myelofibrosis
Bruton's tyrosine kinase inhibitor
Diffuse large B-cell lymphoma
Ibrutinib
Induction chemotherapy
Interferon
Ferritin
Monoclonal antibody
Proteasome inhibitor
Severe Aplastic Anemia
Donor lymphocyte infusion
Bone marrow
Acalabrutinib
Therapeutic Advances in Hematology Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | SAGE PUBLICATIONS LTD |
| Language | English |
| Frequency | Continuous publication |
| Article Processing Charges | USD 2300 |
| Publication Time | 7 |
| Editorial Review Process | Anonymous peer review |
| General Details | |
| Language | English |
| Frequency | Continuous publication |
| Publication Start Year | 2010 |
| Publisher URL | Visit website |
| Website URL | Visit website |
| Publication Details | |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY, CC BY-NC |
| OA statement | Visit website |
View less
Planning to publish in Therapeutic Advances in Hematology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Therapeutic Advances in Hematology
Integrated genetic, epigenetic, and immune landscape of TP53 mutant AML and higher risk MDS treated with azacitidine.
- 1 Jan 2024
- Therapeutic advances in hematology
Vedolizumab for second-line treatment of steroid-refractory gastrointestinal late acute graft-versus-host disease.
- 1 Jan 2024
- Therapeutic advances in hematology
Future needs for continuing innovation in hemophilia: improving outcomes for individuals of all severities, including women and those in resource-constrained regions.
- 1 Jan 2024
- Therapeutic advances in hematology
Iron deficiency anemia: an early clinical presentation of cytomegalovirus-induced hemorrhagic colitis in chronic myeloid leukemia patients under dasatinib treatment.
- 1 Jan 2024
- Therapeutic advances in hematology
Supporting leukemia patients in the Philippines: a call to action
- 1 Jan 2024
- Therapeutic Advances in Hematology
Down syndrome-associated leukaemias: current evidence and challenges.
- 1 Jan 2024
- Therapeutic advances in hematology
Integrated genetic, epigenetic, and immune landscape of TP53 mutant AML and higher risk MDS treated with azacitidine.
- 1 Jan 2024
- Therapeutic advances in hematology
Vedolizumab for second-line treatment of steroid-refractory gastrointestinal late acute graft-versus-host disease.
- 1 Jan 2024
- Therapeutic advances in hematology
Future needs for continuing innovation in hemophilia: improving outcomes for individuals of all severities, including women and those in resource-constrained regions.
- 1 Jan 2024
- Therapeutic advances in hematology
Iron deficiency anemia: an early clinical presentation of cytomegalovirus-induced hemorrhagic colitis in chronic myeloid leukemia patients under dasatinib treatment.
- 1 Jan 2024
- Therapeutic advances in hematology
Supporting leukemia patients in the Philippines: a call to action
- 1 Jan 2024
- Therapeutic Advances in Hematology
Down syndrome-associated leukaemias: current evidence and challenges.
- 1 Jan 2024
- Therapeutic advances in hematology
Compare Similar Journals with Therapeutic Advances in Hematology
Select Journals to Compare with Therapeutic Advances in Hematology
Total journals - 8
You can select up to 3 Journals at a time
Blood
Publisher: AMER SOC HEMATOLOGY
British Journal of Haematology
Publisher: WILEY
Journal of Clinical Oncology
Publisher: LIPPINCOTT WILLIAMS & WILKINS
Annals of Hematology
Publisher: SPRINGER
Blood advances
Publisher: ELSEVIER
American Journal of Hematology
Publisher: WILEY
Haematologica
Publisher: FERRATA STORTI FOUNDATION
Leukemia
Publisher: SPRINGERNATURE
0 Journals Selected to compare with
Therapeutic Advances in Hematology
Compare journals across 7 parameters SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
SJR Ranking, Topics covered, Indexing Database, Publication Review Time, Publication Type, Article Processing Charges & Recently Published papers
Get detailed Journal comparison report on your email by signing up
FAQs on Therapeutic Advances in Hematology
How long has Therapeutic Advances in Hematology been actively publishing? 
Therapeutic Advances in Hematology has been in operation since 2010 till date.
What is the publishing frequency of Therapeutic Advances in Hematology?
Therapeutic Advances in Hematology published with a Continuous publication frequency.
How many articles did Therapeutic Advances in Hematology publish last year?
In 2023, Therapeutic Advances in Hematology publsihed 51 articles.
What is the eISSN & pISSN for Therapeutic Advances in Hematology?
For Therapeutic Advances in Hematology, eISSN is 2040-6215 and pISSN is 2040-6207.
What is Citescore for Therapeutic Advances in Hematology?
Citescore for Therapeutic Advances in Hematology is 0.7.
What is the H Index for Therapeutic Advances in Hematology ?
H Index for Therapeutic Advances in Hematology is 32.
What is SNIP score for Therapeutic Advances in Hematology?
SNIP score for Therapeutic Advances in Hematology is 0.36.
What is the SJR for Therapeutic Advances in Hematology?
SJR for Therapeutic Advances in Hematology is Q2.
Who is the publisher of Therapeutic Advances in Hematology?
SAGE PUBLICATIONS LTD is the publisher of Therapeutic Advances in Hematology.
